Datametrex AI (DM) AI Stock Analysis

• Market Cap: C$2.59M
• Dividend Yield: N/A
• Average Volume (3M): 41.96K
• Price to Earnings (P/E): ―
• Beta (1Y): 2.41
• Revenue Growth: -39.84%
• EPS Growth: 92.78%
• Country: CA
• Employees: 21
• Sector: Technology
• Sector Strength: 87
• Industry: Information Technology Services
• EPS (TTM): N/A
• Shares Outstanding: 32,386,005
• 10 Day Avg. Volume: 42,555
• 30 Day Avg. Volume: 41,958
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Hold
• Number of Analyst Covering: 0

• Rating: 41 Neutral
• Price Target: C$0.00 ▼(-100.00% Downside)

The overall stock score is primarily impacted by significant financial challenges, including declining revenues and negative profitability. Technical analysis also indicates bearish momentum, while valuation metrics are poor with a negative P/E ratio. These factors collectively suggest a high-risk investment.

Positive Factors

AI and Data Analytics Focus

The focus on AI and data analytics positions Datametrex AI in a growing industry with increasing demand for advanced data solutions, potentially driving long-term growth.

Diverse Revenue Streams

Diversified revenue streams from licensing, subscriptions, and consulting provide stability and resilience against market fluctuations, supporting long-term financial health.

Strategic Partnerships

Strategic partnerships enhance Datametrex AI's service offerings and market reach, fostering competitive advantages and potential revenue growth over time.

Negative Factors

Declining Revenue

Significant revenue decline indicates challenges in market demand or competition, potentially impacting long-term sustainability and growth prospects.

High Leverage

High leverage suggests reliance on debt financing, which can strain financial flexibility and increase risk during economic downturns, affecting long-term stability.

Negative Cash Flow

Negative cash flow indicates challenges in generating sufficient cash from operations, potentially limiting investment capacity and financial resilience over time.

Datametrex AI Business Overview & Revenue Model

Company Description

Datametrex AI (DM) is a technology company focused on providing artificial intelligence and data analytics solutions across various sectors, including healthcare, finance, and cybersecurity. The company leverages advanced machine learning and data processing techniques to deliver actionable insights and predictive analytics for businesses, enhancing decision-making processes and operational efficiency. Core products include AI-driven platforms for data management and analysis, as well as specialized tools for market intelligence and risk assessment.

How the Company Makes Money

Datametrex AI generates revenue through a combination of software licensing, subscription services, and consulting fees. The company offers its AI and data analytics solutions on a subscription basis, allowing clients to access its platforms and tools for a recurring fee. Key revenue streams also include one-time licenses for software products, custom consulting services tailored to specific client needs, and partnerships with other technology firms that enhance service offerings. Additionally, Datametrex AI engages in strategic collaborations that expand its market reach and capabilities, contributing to its overall earnings.

Datametrex AI Financial Statement Overview

Summary

Datametrex AI Limited is facing significant financial challenges, with declining revenues, negative profitability margins, and high leverage. The company's ability to generate cash flow is compromised, making it imperative to address operational inefficiencies and improve profitability to ensure long-term sustainability.

Income Statement

The income statement shows a declining trend in revenue growth from 2022 to 2024, with a significant decline from 2021 levels. Gross profit margins have decreased, and the company is experiencing negative EBIT and EBITDA margins, indicating operational inefficiencies. The net profit margin is also negative due to substantial net losses, reflecting challenges in achieving profitability.

Balance Sheet

The balance sheet reveals a high debt-to-equity ratio, indicating significant leverage, which could pose financial risks. The equity ratio is relatively low, suggesting limited asset backing by equity. However, the company has managed to maintain positive stockholders' equity, though it has decreased over recent years. Return on equity is negative, highlighting profitability issues.

Cash Flow

The cash flow statement indicates negative operating and free cash flows in recent years, reflecting challenges in generating cash from core operations. The free cash flow to net income ratio is negative due to net losses, and the operating cash flow to net income ratio is also negative, raising concerns about cash flow sustainability.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	6.11M	6.49M	7.80M	30.49M	49.03M	12.38M
Gross Profit	2.42M	3.07M	2.17M	10.20M	21.03M	2.99M
EBITDA	-928.51K	-1.24M	-6.95M	-13.46M	13.29M	-3.60M
Net Income	-2.66M	-3.06M	-19.14M	-17.26M	9.09M	-5.01M
Balance Sheet
Total Assets	5.96M	4.99M	12.71M	36.00M	42.64M	10.00M
Cash, Cash Equivalents and Short-Term Investments	253.76K	427.11K	1.13M	9.41M	17.99M	1.97M
Total Debt	2.14M	1.84M	5.19M	4.53M	253.77K	518.58K
Total Liabilities	4.87M	4.33M	11.70M	13.23M	10.15M	6.75M
Stockholders Equity	1.09M	656.40K	1.00M	22.77M	32.49M	3.25M
Cash Flow
Free Cash Flow	-2.01M	-1.57M	-6.94M	-2.28M	11.42M	-611.50K
Operating Cash Flow	-1.70M	-1.22M	-5.62M	-249.09K	11.45M	-595.10K
Investing Cash Flow	-273.93K	59.10K	-969.15K	-3.79M	-234.41K	-14.93K
Financing Cash Flow	1.84M	1.21M	-254.18K	-2.40M	2.19M	2.48M

Datametrex AI Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	61 Neutral	$36.80B	11.76	-10.20%	1.85%	8.54%	-7.31%
VIS	45 Neutral	C$3.87M	―	-3428.85%	―	-15.33%	47.13%
DM	41 Neutral	C$2.59M	―	-49.91%	―	-39.84%	92.78%
FARM	40 Underperform	C$8.31M	―		―	-15.73%	-45.92%
NOSUF	―	$1.61M	―		―	―	―
PAID	41 Neutral	C$8.07M	―	99.64%	―	30.97%	18.42%
DCSX	―	$5.57M	―		―	―	―

Datametrex AI Corporate Events

Datametrex AI Limited to Acquire Arbutus Health and Wellness Inc.

Datametrex AI Limited has signed a non-binding Letter of Intent to acquire Arbutus Health and Wellness Inc., a multidisciplinary medical clinic in Vancouver, for up to $1.1 million through common shares. This strategic acquisition aims to expand Datametrex’s healthcare business, strengthen its sector presence, and align with its long-term growth strategy. Additionally, Richard Yoon has resigned from the Board of Directors, and the company is in the process of identifying a suitable replacement.

Datametrex AI Limited Unveils Strategic Focus on Healthcare and AI

Datametrex AI Limited has announced a strategic plan to focus on its healthcare and AI businesses by expanding clinic operations and strengthening AI services. The company plans to acquire additional clinics, wind down non-core businesses, and split into two entities to enhance operational efficiency and shareholder value.

Datametrex AI Announces Share Consolidation Effective Date

Datametrex AI Limited has announced the effective date for its share consolidation, where its common shares will begin trading on a consolidated basis of one post-consolidation share for every thirty pre-consolidation shares on the TSX Venture Exchange. This move will adjust the total issued and outstanding number of shares to approximately 21,002,671, potentially impacting the company’s market dynamics and investor relations.

Datametrex AI Limited Proposes Share Consolidation for Capital Optimization

Datametrex AI Limited announced a proposed consolidation of its common shares, aiming to optimize the capital structure and attract financing. The consolidation will change the share ratio to one new share for every thirty existing shares, reducing the number of shares from 630,080,158 to 21,002,671, subject to regulatory approval. This move is expected to impact the company’s operations by potentially improving its financial flexibility and attractiveness to investors.

Datametrex AI Limited’s Subsidiary Secures $1.1M Service Order

Datametrex AI Limited announced that its subsidiary, Datametrex Korea, has received purchase orders valued at approximately $1.1 million for service and tech support, with a projected gross profit margin of 63%. This achievement highlights the company’s ongoing financial growth and its dedication to strengthening client partnerships and expanding its industry presence.